Stay updated on Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial

Sign up to get notified when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    No additions or deletions were observed between the old and new versions of the page.
    Difference
    0.4%
    Check dated 2025-11-03T01:15:45.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    3%
    Check dated 2025-10-05T10:06:55.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Page updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.
    Difference
    0.4%
    Check dated 2025-09-28T03:13:36.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-13T16:58:52.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, and a 'Back to Top' feature has been added.
    Difference
    0.2%
    Check dated 2025-09-06T14:28:20.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new drug information related to Dolutegravir and various medical topics. Notably, the previous drug information for Dolutegravir has been removed, indicating a shift in focus.
    Difference
    6%
    Check dated 2025-08-30T11:16:57.000Z thumbnail image

Stay in the know with updates to Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.